BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Qiao-Ling Xie, Ying Zhu, Ling-Hong Wu, Lin-Lin Fu, Yan Xiang, Chen-Hua Liu. The Efficacy and Safety of Entecavir and Interferon Combination Therapy for Chronic Hepatitis B Virus Infection: A Meta-AnalysisPLOS ONE 2015; 10(7): e0132219 doi: 10.1371/journal.pone.0132219
2
Benjamin W Teh, Monica A Slavin, Simon J Harrison, Leon J Worth. Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunizationExpert Review of Anti-infective Therapy 2015; 13(11): 1325 doi: 10.1586/14787210.2015.1083858
3
Jonas Michel Wolf, Vagner Reinaldo Zingalli Bueno Pereira, Patrícia Andréia Zanetti Ballardin Roncato, André Castagna Wortmann, Glaucia Zuleide Stumm, Fernando Oliveira da Silva, Vagner Ricardo Lunge, Daniel Simon. The HLA-G 14-bp insertion/deletion polymorphism is associated with chronic hepatitis B in Southern Brazil: A case-control studyHuman Immunology 2020; 81(2-3): 79 doi: 10.1016/j.humimm.2020.01.003
4
Qianying Chen, Hongzhu Chen, Wenjie Wang, Jiali Liu, Wenyue Liu, Ping Ni, Guowei Sang, Guangji Wang, Fang Zhou, Jingwei Zhang. Glycyrrhetic acid, but not glycyrrhizic acid, strengthened entecavir activity by promoting its subcellular distribution in the liver via efflux inhibitionEuropean Journal of Pharmaceutical Sciences 2017; 106: 313 doi: 10.1016/j.ejps.2017.06.015
5
Johan Noble, Thomas Jouve, Paolo Malvezzi, Lionel Rostaing. Renal complications of liver diseasesExpert Review of Gastroenterology & Hepatology 2018; 12(11): 1135 doi: 10.1080/17474124.2018.1530984
6
Longgen Liu, Jianchun Lu, Chunyan Ye, Lin Lin, Shuqin Zheng, Hongyu Zhang, Qing Lan, Yuan Xue. Serum osteopontin is a predictor of prognosis for HBV‑associated acute‑on‑chronic liver failureBiomedical Reports 2017;  doi: 10.3892/br.2017.1027
7
Ashish Goyal, John M. Murray. Cost-Effectiveness of Peg-Interferon, Interferon and Oral Nucleoside Analogues in the Treatment of Chronic Hepatitis B and D Infections in ChinaClinical Drug Investigation 2016; 36(8): 637 doi: 10.1007/s40261-016-0409-8
8
X. Wen, H. Su, Y. Wang, Z. Pu, J. Gao, Z. Ji, X. Yuan, X. Li, W. Zhang, L. Zhang, Y. Long, Y. Yan, Z. Shao. Prevalence and natural course of occult hepatitis B virus infection in residents of 2 communities of Wuwei City, Gansu Province, ChinaJournal of Viral Hepatitis 2018; 25(3): 281 doi: 10.1111/jvh.12805
9
Longgen Liu, Qing Lan, Lin Lin, Jianchun Lu, Chunyan Ye, Qian Tao, Manman Cui, Shuqin Zheng, Xiujun Zhang, Yuan Xue. Gamma-glutamyl transpeptidase-to-platelet ratio predicts the prognosis in HBV-associated acute-on-chronic liver failureClinica Chimica Acta 2018; 476: 92 doi: 10.1016/j.cca.2017.11.017
10
Florence Defresne, Etienne Sokal. Chronic hepatitis B in children: Therapeutic challenges and perspectivesJournal of Gastroenterology and Hepatology 2017; 32(2): 368 doi: 10.1111/jgh.13459
11
Maritza Puray-Chavez, Mahmoud Farghali, Vincent Yapo, Andrew Huber, Dandan Liu, Tanyaradzwa Ndongwe, Mary Casey, Thomas Laughlin, Mark Hannink, Philip Tedbury, Stefan Sarafianos. Effects of Moloney Leukemia Virus 10 Protein on Hepatitis B Virus Infection and Viral ReplicationViruses 2019; 11(7): 651 doi: 10.3390/v11070651
12
Andrew D. Huber, Dallas L. Pineda, Dandan Liu, Kelsey N. Boschert, Anna T. Gres, Jennifer J. Wolf, Emily M. Coonrod, Jing Tang, Thomas G. Laughlin, Qiongying Yang, Maritza N. Puray-Chavez, Juan Ji, Kamalendra Singh, Karen A. Kirby, Zhengqiang Wang, Stefan G. Sarafianos. Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral CoresACS Infectious Diseases 2019; 5(5): 750 doi: 10.1021/acsinfecdis.8b00235
13
Masatoshi Kakizaki, Yuichiro Yamamoto, Suemi Yabuta, Natsumi Kurosaki, Tatehiro Kagawa, Ai Kotani, Motoyuki Otsuka. The immunological function of extracellular vesicles in hepatitis B virus-infected hepatocytesPLOS ONE 2018; 13(12): e0205886 doi: 10.1371/journal.pone.0205886
14
Eduardo Asín-Prieto, Zinnia P. Parra-Guillen, José David Gómez Mantilla, Joris Vandenbossche, Kim Stuyckens, Xavier Woot de Trixhe, Juan José Perez-Ruixo, Iñaki F. Troconiz. Immune network for viral hepatitis B: Topological representationEuropean Journal of Pharmaceutical Sciences 2019; 136: 104939 doi: 10.1016/j.ejps.2019.05.017
15
Elaheh Gholami Parizad, Eskandar Gholami Parizad, Afra Khosravi, Mansour Amraei, Azar Valizadeh, Abdoullah Davoudian. Comparing HBV Viral Load in Serum, Cerumen, and Saliva and Correlation With HBeAg Serum Status in Patients With Chronic Hepatitis B InfectionHepatitis Monthly 2016; 16(5) doi: 10.5812/hepatmon.30385
16
Edward A. Pham, Ryan B. Perumpail, Benjamin J. Fram, Jeffrey S. Glenn, Aijaz Ahmed, Robert G. Gish. Future Therapy for Hepatitis B Virus: Role of ImmunomodulatorsCurrent Hepatology Reports 2016; 15(4): 237 doi: 10.1007/s11901-016-0315-9
17
En-Qiang Chen, Shu Feng, Meng-Lan Wang, Ling-Bo Liang, Ling-Yun Zhou, Ling-Yao Du, Li-Bo Yan, Chuan-Min Tao, Hong Tang. Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis BScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00111-0
18
Chen Tian, Yuxin Chen, Yong Liu, Shixia Wang, Yang Li, Guiyang Wang, Juan Xia, Xiang-an Zhao, Rui Huang, Shan Lu, Chao Wu. Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humansEmerging Microbes & Infections 2018; 7(1): 1 doi: 10.1038/s41426-018-0034-0
19
Zhongji Meng, Xiaoyong Zhang, Rongjuan Pei, Ejuan Zhang, Thekla Kemper, Jörg Vollmer, Heather L. Davis, Dieter Glebe, Wolfram Gerlich, Michael Roggendorf, Mengji Lu. Combination therapy including CpG oligodeoxynucleotides and entecavir induces early viral response and enhanced inhibition of viral replication in a woodchuck model of chronic hepadnaviral infectionAntiviral Research 2016; 125: 14 doi: 10.1016/j.antiviral.2015.11.001
20
Catherine de Martel, Delphine Maucort‐Boulch, Martyn Plummer, Silvia Franceschi. World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinomaHepatology 2015; 62(4): 1190 doi: 10.1002/hep.27969
21
Yang Zheng, Jie Wu, Cheng Ding, Kaijin Xu, Shigui Yang, Lanjuan Li. Disease burden of chronic hepatitis B and complications in China from 2006 to 2050: an individual-based modeling studyVirology Journal 2020; 17(1) doi: 10.1186/s12985-020-01393-z
22
Melanie L Yarbrough, Carey-Ann D Burnham. The ABCs of STIs: An Update on Sexually Transmitted InfectionsClinical Chemistry 2016; 62(6): 811 doi: 10.1373/clinchem.2015.240234
23
Giordano Madeddu, Silvia Ortu, Giovanni Garrucciu, Ivana Maida, Michela Melis, Alberto Augusto Muredda, Maria Stella Mura, Sergio Babudieri. DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapyJournal of Medical Virology 2017; 89(7): 1208 doi: 10.1002/jmv.24742
24
Eugene Verkhovsky, Paul Naylor, Sindhuri Benjaram, Shanker Das Kundumadam, Murray Ehrinpreis, Milton Mutchnick. Racial disparity in chronic hepatitis B infection in a predominately African American urban clinic populationAIMS Medical Science 2018; 5(4): 378 doi: 10.3934/medsci.2018.4.378
25
Jianchun Lu, Lin Lin, Chunyan Ye, Qian Tao, Manman Cui, Shuqin Zheng, Dongmei Zhu, Longgen Liu, Yuan Xue. Serum NGAL Is Superior to Cystatin C in Predicting the Prognosis of Acute-on-Chronic Liver FailureAnnals of Hepatology 2019; 18(1): 155 doi: 10.5604/01.3001.0012.7907
26
Hui Wang, KeHui Liu, Bernard A. M. Fang, HaiQing Wu, FengDi Li, XiaoGang Xiang, WeiLiang Tang, GangDe Zhao, LanYi Lin, Shisan Bao, Qing Xie. Identification of acetyltransferase genes (HAT1 and KAT8) regulating HBV replication by RNAi screeningCell & Bioscience 2015; 5(1) doi: 10.1186/s13578-015-0059-1
27
Hans L. Tillmann, Gbeminiyi Samuel. Current state-of-the-art pharmacotherapy for the management of hepatitis B infectionExpert Opinion on Pharmacotherapy 2019; 20(7): 873 doi: 10.1080/14656566.2019.1583744
28
Joel S. Emery, Jordan J. Feld. Treatment of hepatitis B virus with combination therapy now and in the futureBest Practice & Research Clinical Gastroenterology 2017; 31(3): 347 doi: 10.1016/j.bpg.2017.04.007
29
涛 巫. Immunotherapy for Chronic Hepatitis B Virus InfectionPharmacy Information 2019; 8(03): 105 doi: 10.12677/PI.2019.83013
30
Gao-yun Chen, Min Liu, Meng-bin Yu, Chao Zheng, Si-chen Wei, I. Demetrescu, K. Oh, N.K. Kaushik, A. Butu, F. Othman. Study on the Chemical Constituents and anti-HBV Activity ofHypericum japonicaMATEC Web of Conferences 2016; 60: 03002 doi: 10.1051/matecconf/20166003002
31
Wen-Pei Wu, Cheng-In Hoi, Ran-Chou Chen, Ching-Po Lin, Chen-Te Chou. Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosisMedicine 2017; 96(42): e8339 doi: 10.1097/MD.0000000000008339
32
Tung-Hung Su, Jia-Horng Kao. Improving clinical outcomes of chronic hepatitis B virus infectionExpert Review of Gastroenterology & Hepatology 2015; 9(2): 141 doi: 10.1586/17474124.2015.960398
33
Zhao X. Hu, Yi N. Ye, Wei G. Wu, Xu J. Liang, Qi W. Wu, Ao Zhang, Xing R. Zheng, Zhi L. Gao, Liang Peng, Chan Xie. Real-Life State of Anti-Hepatitis B Virus Drug Choice in Child-Bearing Age Male Patients and Effect on Fertility and Fetal SafetyCanadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/9703907
34
Yin Zhang, Yanming Xie, Yiying Zhang, Yan Liu, Yan Zhuang. Hepatitis B patients exhibiting mild alanine aminotransferase elevation: A comparative analysis of treatment with and without Bicyclol tabletsBiomedical Reports 2016; 5(5): 595 doi: 10.3892/br.2016.765
35
Yiyu Lu, Zhaoyuan Fang, Tao Zeng, Meiyi Li, Qilong Chen, Hui Zhang, Qianmei Zhou, Yiyang Hu, Luonan Chen, Shibing Su. Chronic hepatitis B: dynamic change in Traditional Chinese Medicine syndrome by dynamic network biomarkersChinese Medicine 2019; 14(1) doi: 10.1186/s13020-019-0275-4
36
Ramesh P Thylur, Sanjit K Roy, Anju Shrivastava, Thomas A LaVeist, Sharmila Shankar, Rakesh K Srivastava. Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinomaJGH Open 2020; 4(3): 351 doi: 10.1002/jgh3.12336
37
Jun-Feng Li, Xiao-Peng Dai, Wei Zhang, Shi-Hui Sun, Yang Zeng, Guang-Yu Zhao, Zhi-Hua Kou, Yan Guo, Hong Yu, Lan-Ying Du, Shi-Bo Jiang, Yu-Sen Zhou, John M. Taylor, Michael J. Imperiale. Upregulation of MicroRNA-146a by Hepatitis B Virus X Protein Contributes to Hepatitis Development by Downregulating Complement Factor HmBio 2015; 6(2) doi: 10.1128/mBio.02459-14
38
Michelle Pardee. Diagnosis and Management of Hepatitis B and CNursing Clinics of North America 2019; 54(2): 277 doi: 10.1016/j.cnur.2019.02.004
39
Shu-Rong Xiao, Gui-Dan Xu, Wu-Jun Wei, Bin Peng, Yi-Bin Deng. Antiviral effects of hepatitis B virus S gene-specific anti-gene locked nucleic acid in transgenic miceWorld Journal of Clinical Cases 2018; 6(8): 183-191 doi: 10.12998/wjcc.v6.i8.183
40
Knut Stokkeland, Jonas Filip Ludvigsson, Rolf Hultcrantz, Anders Ekbom, Jonas Höijer, Matteo Bottai, Olof Stephansson. Pregnancy outcome in more than 5000 births to women with viral hepatitis: a population-based cohort study in SwedenEuropean Journal of Epidemiology 2017; 32(7): 617 doi: 10.1007/s10654-017-0261-z
41
Dengke Teng, Hao Zuo, Lin Liu, Jinghui Dong, Lei Ding. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatmentVirology Journal 2018; 15(1) doi: 10.1186/s12985-018-1067-7
42
M. A. A. van de Klundert, H. L. Zaaijer, N. A. Kootstra. Identification of FDA-approved drugs that target hepatitis B virus transcriptionJournal of Viral Hepatitis 2016; 23(3): 191 doi: 10.1111/jvh.12479
43
Shahnaz Sali, Maryam Nasiri. Tenofovir Response Rate and Adverse Effects in Patients with Chronic Hepatitis B Attending to Hepatitis Clinic at Labbafinejad HospitalJundishapur Journal of Natural Pharmaceutical Products 2019; 14(3) doi: 10.5812/jjnpp.63023
44
Jinlin Hou, Guiqiang Wang, Fusheng Wang, Jun Cheng, Hong Ren, Hui Zhuang, Jian Sun, Lanjuan Li, Jie Li, Qinghua Meng, Jingmin Zhao, Zhongping Duan, Jidong Jia, Hong Tang, Jifang Sheng, Jie Peng, Fengmin Lu, Qing Xie, Lai Wei. Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)Journal of Clinical and Translational Hepatology 2017; 5(4): 297 doi: 10.14218/JCTH.2016.00019
45
Seung-Hwa Choi, Keum-Jin Yang, Dong-Soo Lee. Effects of Complementary Combination Therapy of Korean Red Ginseng and Antiviral Agents in Chronic Hepatitis BThe Journal of Alternative and Complementary Medicine 2016; 22(12): 964 doi: 10.1089/acm.2015.0206
46
Lu Xu, Tian Xie, Tao Shen, Shengnan Jian. Yinchenhao decoction for chronic hepatitis BMedicine 2019; 98(8): e14648 doi: 10.1097/MD.0000000000014648
47
Ja Yoon Heo, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Young Nyun Park, Sung Soo Ahn, Kwang-Hyub Han, Hyon-Suk Kim. Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B VirusMedicine 2016; 95(14): e3328 doi: 10.1097/MD.0000000000003328
48
Soheil Tavakolpour, Hajar Sadat Mirsafaei, Somayeh Elkaei Behjati, Mojtaba Ghasemiadl, Meisam Akhlaghdoust, Shahnaz Sali. Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapyImmunology Letters 2017; 190: 206 doi: 10.1016/j.imlet.2017.08.003
49
Ceen-Ming Tang. Abnormal liver function testsInnovAiT: Education and inspiration for general practice 2019; 12(9): 507 doi: 10.1177/1755738019855092
50
Yuichiro Yamamoto, Masatoshi Kakizaki, Takayuki Shimizu, Joaquim Carreras, Tetsuhiro Chiba, Kenji Chamoto, Tatehiro Kagawa, Taku Aoki, Naoya Nakamura, Kiyoshi Ando, Ai Kotani. PD-L1 is induced on the hepatocyte surface via CKLF-like MARVEL transmembrane domain-containing protein 6 up-regulation by the anti-HBV drug EntecavirInternational Immunology 2020; 32(8): 519 doi: 10.1093/intimm/dxaa018
51
Mikiko Nakamura, Ayako Suzuki, Junko Akada, Keisuke Tomiyoshi, Hisashi Hoshida, Rinji Akada. End Joining-Mediated Gene Expression in Mammalian Cells Using PCR-Amplified DNA Constructs that Contain Terminator in Front of PromoterMolecular Biotechnology 2015; 57(11-12): 1018 doi: 10.1007/s12033-015-9890-1
52
Sobia Manzoor, Muhammad Saalim, Muhammad Imran, Saleha Resham, Javed Ashraf. Hepatitis B virus therapy: What’s the future holding for us?World Journal of Gastroenterology 2015; 21(44): 12558-12575 doi: 10.3748/wjg.v21.i44.12558
53
Tony Mazzulli. Principles and Practice of Pediatric Infectious Diseases2018; : 1434 doi: 10.1016/B978-0-323-40181-4.00287-5
54
P. H. Naylor, M. G. Mutchnick. Immunotherapy for hepatitis B in the direct acting antiviral era: Reevaluating the thymosin α1 efficacy trials in the light of a combination therapy approachJournal of Viral Hepatitis 2018; 25(1): 4 doi: 10.1111/jvh.12807
55
Getu Zhaori. Potential clinical application of RNAi-based therapeutic strategies for treatment of chronic hepatitis BPediatric Investigation 2018; 2(1): 4 doi: 10.1002/ped4.12018
56
Song Yang, Huichun Xing, Yuming Wang, Jinlin Hou, Duande Luo, Qing Xie, Qin Ning, Hong Ren, Huiguo Ding, Jifang Sheng, Lai Wei, Shijun Chen, Xiaoling Fan, Wenxiang Huang, Chen Pan, Zhiliang Gao, Jiming Zhang, Boping Zhou, Guofeng Chen, Mobin Wan, Hong Tang, Guiqiang Wang, Yuxiu Yang, Dongping Xu, Peiling Dong, Qixin Wang, Jue Wang, Fernando A. Bognar, Daozhen Xu, Jun Cheng. HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patientsVirology Journal 2016; 13(1) doi: 10.1186/s12985-016-0640-1
57
Vanessa Meier-Stephenson, William Bremner, Chimone Dalton, Guido van Marle, Carla Coffin, Trushar Patel. Comprehensive Analysis of Hepatitis B Virus Promoter Region MutationsViruses 2018; 10(11): 603 doi: 10.3390/v10110603
58
Fangfang Fu, Xiaodong Li, Qiuyu Liu, Cuiyun Chen, Yan Bai, Dapeng Shi, Jia Sang, Kaiyu Wang, Meiyun Wang. Noninvasive DW-MRI metrics for staging hepatic fibrosis and grading inflammatory activity in patients with chronic hepatitis BAbdominal Radiology 2020;  doi: 10.1007/s00261-020-02801-2
59
Daniel N Clark, Jianming Hu. Unveiling the roles of HBV polymerase for new antiviral strategiesFuture Virology 2015; 10(3): 283 doi: 10.2217/fvl.14.113
60
Qi-wen Chen, Hai-jin Li, Ya-nan Chen, Zhou-yu Ning, Song Gao, Ye-hua Shen, Zhi-qiang Meng, Sonya Vargulick, Bi-yun Wang, Hao Chen, Do Young Kim. Hepatic Lesions Detected after Mastectomy, in Breast Cancer Patients with Hepatitis Background May Need to Undergo Liver Biopsy to Rule Out Second Primary Hepatocellular CarcinomaPLOS ONE 2016; 11(1): e0139782 doi: 10.1371/journal.pone.0139782
61
Elaine Tang, Sharon Torres, Benny Liu, Rachel Baden, Taft Bhuket, Robert J. Wong. High Prevalence of Cirrhosis at Initial Presentation Among Safety-Net Adults with Chronic Hepatitis B Virus InfectionJournal of Clinical and Experimental Hepatology 2018; 8(3): 235 doi: 10.1016/j.jceh.2017.11.009
62
Jian Sun, Huiguo Ding, Guofeng Chen, Guiqiang Wang, Lai Wei, Jiming Zhang, Qing Xie, Mobin Wan, Hong Tang, Shijun Chen, Zhiliang Gao, Yuming Wang, Dazhi Zhang, Wenxiang Huang, Jifang Sheng, Qin Ning, Dongliang Yang, Jian Lu, Chen Pan, Yuxiu Yang, Jue Wang, Chuanzhen Sun, Qixin Wang, Jinlin Hou. Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in ChinaBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0981-5
63
Carla S. Coffin, Samuel S. Lee. New paradigms in hepatitis B management: only diamonds are foreverBritish Medical Bulletin 2015; : ldv039 doi: 10.1093/bmb/ldv039
64
Mai Hashimoto, Kazuaki Taguchi, Takako Ishiguro, Satoru Kohgo, Shuhei Imoto, Keishi Yamasaki, Hiroaki Mitsuya, Masaki Otagiri. Pharmacokinetics studies of 4′-cyano-2′-deoxyguanosine, a potent inhibitor of the hepatitis B virus, in ratsJournal of Pharmacy and Pharmacology 2018; 70(6): 723 doi: 10.1111/jphp.12897
65
Pu Zhou, Feifei Yang, Jinyu Wang, Richeng Mao, Xun Qi, Yuxian Huang, Jiming Zhang. Improved Efficacy of a Pegylated Interferon-α-2a Stepwise Optimization Treatment Strategy in the Treatment of Hepatitis B e Antigen-positive Chronic Hepatitis B PatientsMedicine 2015; 94(17): e730 doi: 10.1097/MD.0000000000000730
66
Natascha Roehlen, Emilie Crouchet, Thomas F. Baumert. Liver Fibrosis: Mechanistic Concepts and Therapeutic PerspectivesCells 2020; 9(4): 875 doi: 10.3390/cells9040875
67
Nicholas A. Meanwell. 2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry TriumphJournal of Medicinal Chemistry 2016; 59(16): 7311 doi: 10.1021/acs.jmedchem.6b00915
68
Lesley J. Scott, Henry L. Y. Chan. Tenofovir Alafenamide: A Review in Chronic Hepatitis BDrugs 2017; 77(9): 1017 doi: 10.1007/s40265-017-0754-9
69
Andrew D. Huber, Eleftherios Michailidis, Jing Tang, Maritza N. Puray-Chavez, Maria Boftsi, Jennifer J. Wolf, Kelsey N. Boschert, Megan A. Sheridan, Maxwell D. Leslie, Karen A. Kirby, Kamalendra Singh, Hiroaki Mitsuya, Michael A. Parniak, Zhengqiang Wang, Stefan G. Sarafianos. 3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease HAntimicrobial Agents and Chemotherapy 2017; 61(6) doi: 10.1128/AAC.00245-17
70
Wen-xiong Xu, Qian Zhang, Xiang Zhu, Chao-shuang Lin, You-ming Chen, Hong Deng, Yong-yu Mei, Zhi-xin Zhao, Dong-ying Xie, Zhi-liang Gao, Chan Xie, Liang Peng. 48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with RelapseCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/1817680
71
Tai-Ping Li, Shi-He Guan, Qin Wang, Li-Wen Chen, Kai Yang, Hao Zhang. Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failureWorld Journal of Gastroenterology 2019; 25(37): 5667-5675 doi: 10.3748/wjg.v25.i37.5667
72
Behnam Azizolahi, Elham Rajaei, Reza Taherkhani, Manoochehr Makvandi. Low detection of hepatitis B and occult hepatitis B infection in patients with rheumatic diseasesThe Egyptian Rheumatologist 2017; 39(4): 239 doi: 10.1016/j.ejr.2017.04.009
73
Chunlin Li, Yu Yang, Yingjian Wang, Shurong Dong, Ya Yang, Ying Shi, Linhan Li, Feng Jiang, Yue Chen, Qingwu Jiang, Yibiao Zhou. Impact of maternal HIV–HBV coinfection on pregnancy outcomes in an underdeveloped rural area of southwest ChinaSexually Transmitted Infections 2020; 96(7): 509 doi: 10.1136/sextrans-2019-054295
74
Ji Yun Lee, Sung Hee Lim, Min-Young Lee, Haesu Kim, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Chul Won Jung, Jun Ho Jang, Won Seog Kim, Seok Jin Kim, Kihyun Kim. Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapyLiver International 2015; 35(11): 2363 doi: 10.1111/liv.12838
75
Rongxin Wang, Ruiling Xie, Zongchang Song. Circulating regulatory Tfh cells are enriched in patients with chronic hepatitis B infection and induce the differentiation of regulatory B cellsExperimental Cell Research 2018; 365(2): 171 doi: 10.1016/j.yexcr.2018.02.031
76
Chun-Ta Lin, Yue-Ting Hsieh, Yeng-Jey Yang, Shih-Hui Chen, Cheng-Hsuan Wu, Lih-Hwa Hwang. B-Cell Lymphoma 6 (BCL6) Is a Host Restriction Factor That Can Suppress HBV Gene Expression and Modulate Immune ResponsesFrontiers in Microbiology 2019; 9 doi: 10.3389/fmicb.2018.03253
77
Wei Wu, Yu Zhu, Chenbo Yu, Shigui Yang, Bing Ruan, Yu Chen, Lanjuan Li. Clinical features of treatment-naive patients with hepatitis B virus infectionMedicine 2017; 96(16): e6660 doi: 10.1097/MD.0000000000006660
78
Zahari Krastev, Diana Petrova, Iskren Kotzev, Mustafa Kemal Celen, Meryl Mendelson, Richa Chandra, Priti Pandey, Kamal Hamed. Telbivudine <i>vs</i> tenofovir in hepatitis B e antigen-negative chronic hepatitis B patients: OPTIMA roadmap studyWorld Journal of Hepatology 2016; 8(32): 1402-1413 doi: 10.4254/wjh.v8.i32.1402
79
Xiao Li, Tai-Cheng Zhou, Chang-Hui Wu, Li-Lin Tao, Rui Bi, Li-Jun Chen, De-Yao Deng, Chang Liu, Newton O. Otecko, Yang Tang, Xin Lai, Liang Zhang, Jia Wei. Correlations between mitochondrial DNA haplogroup D5 and chronic hepatitis B virus infection in Yunnan, ChinaScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-19184-6
80
Xiaoyu Fu, Yi Ouyang, Juan Mo, Ronghua Li, Lei Fu, Shifang Peng. Upregulation of microRNA-328-3p by hepatitis B virus contributes to THLE-2 cell injury by downregulating FOXO4Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02299-8
81
F. C. van der Scheun, M. C. M. Nagelkerke, A. Kilaru, V. Shridhar, R. Prasad, T. S. van der Werf. Stigma among healthcare workers towards hepatitis B infection in Bangalore, India: a qualitative studyBMC Health Services Research 2019; 19(1) doi: 10.1186/s12913-019-4606-z